Sanofi S.A., FR0000120578

Sanofi stock trades at EUR 71.59 versus EUR 71.80, minus 0.29 percent

Published on 09/30/2026 at 09:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi stock was at EUR 71.59 at Lang & Schwarz on September 30, 2026, versus EUR 71.80 and minus 0.29 percent. Business EPS rose 33.30 percent in Q2 2026.

Modern pharmaceutical sterile fill-and-finish manufacturing facility interior with glass vial-filling machines and cleanroom workers in white suits — Sanofi FR0000120578 photorealistic sterile fill-and-finish facility with vial-filling machines and cleanroom workers, Illustration mit AI erstellt.

Sanofi stock (ISIN FR0000120578) was trading at EUR 71.59 at Lang & Schwarz on September 30, 2026 at 9:07 a.m. CEST, versus the prior close of EUR 71.80 and minus 0.29 percent. The company entered a new portfolio transaction with Cheplapharm while its second-quarter operating figures showed faster earnings growth than sales.

Q2 sales rose 17.80 percent

According to ScanX, Sanofi reported second-quarter 2026 net sales of EUR 11.60 billion, up 17.80 percent from the prior-year quarter. Business earnings per share increased 33.30 percent, and business operating income rose 35.80 percent.

The comparison matters because earnings expanded faster than revenue in Q2 2026. Sanofi's IFRS net income was EUR 343.00 million for the quarter, according to the standardized financial statement data for June 30, 2026.

Cheplapharm deal changes the mix

Sanofi said on September 14, 2026, that Cheplapharm would take over 20 mature medicines and three manufacturing sites, while Sanofi would receive a 26.40 percent equity stake. The Sanofi release said the transaction was not expected to affect 2026 financial guidance.

The regulatory timetable adds a dated checkpoint. The Finanznachrichten reported a merger-control filing dated September 24, 2026, covering Sanofi's planned minority investment in Cheplapharm.

Analyst target stays at EUR 95.00

Deutsche Bank Research kept its Buy rating and EUR 95.00 target on September 15, 2026, according to MarketScreener. The target is EUR 23.41 above the Lang & Schwarz price, placing the analyst reference above the September 30, 2026 quotation.

Sanofi stock holds near yearly low

Sanofi stock was trading at EUR 71.59 at Lang & Schwarz on September 30, 2026 at 9:07 a.m. CEST, minus 0.29 percent versus the EUR 71.80 prior close. Boursorama lists Euronext Paris as the primary market and shows a 52-week range of EUR 70.96 to EUR 91.15 as of September 29, 2026, with market capitalization of EUR 86.3 billion.